Disease Associations
Hepatitis C Patients with Kidney Disease See Limited Relief with Interferon
Published in Hepatitis Weekly, January 29th, 2001
Hepatitis C virus (HCV) not only impacts the liver, but has been associated with a chronic disease of the kidneys called cryoglobulinemic glomerulonephritis. In the past, this disease has been treated with immunosuppressive therapies, but that is no longer recommended for patients with viral infections.
The new research was performed in Italy, where 13 patients were randomly assigned to receive six months of treatment with prednisone, a steroid commonly used for treating...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2001-01-29)
More Articles from Hepatitis Weekly
- Pharmacokinetics
Pegylated Interferon-alpha Therapy Profiled for Chronic Hepatitis C Patients - Disease Associations
Non-Specific Route Lines Path to Hepatocellular Carcinoma in Hepatitis B and C - Hemodialysis
High-Biocompatible Filters Reduce Hepatitis C Transmission Risk - Hepatocellular Carcinoma
Interferon Receptors on Liver Tissues are Up-Regulated by Inflammatory Cytokines - Immunization
Organization Uses Different Approach to Increase Hepatitis Vaccine Awareness - Kidney Transplantation
Liver Function Tests Parallel Liver Appearance after Transplantation - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
